scispace - formally typeset
J

Juan Ma

Researcher at Yanbian University

Publications -  55
Citations -  1379

Juan Ma is an academic researcher from Yanbian University. The author has contributed to research in topics: NF-κB & IκBα. The author has an hindex of 19, co-authored 50 publications receiving 773 citations.

Papers
More filters
Journal ArticleDOI

Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-κB and TNF-α/TNFR1/NF-κB pathways.

TL;DR: This study has investigated the antidepressant mechanism of arctigenin by conducting in vitro and in vivo studies, and found that proinflammatory cytokines in microglia via high‐mobility group box 1 (HMGB1)/TLR4/NF‐κB and TNF‐α/TNFR1/NF-κB signalling pathways, leading to depression.
Journal ArticleDOI

Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.

TL;DR: It is suggested that imperatorin is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity.
Journal ArticleDOI

Artemisinin inhibits inflammatory response via regulating NF-κB and MAPK signaling pathways.

TL;DR: The anti-inflammatory effects of artemisinin in TPA-induced skin inflammation in mice were demonstrated and it was proved that art Artemisinin potentiated TNF-α-induced apoptosis.
Journal ArticleDOI

Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1α and STAT3 in human colon cancer cells

TL;DR: Investigation of the potential activity of panaxadiol on programmed cell death-ligand 1 (PD-L1) expression and tumour proliferation in human colon cancer cells and the underlying mechanism revealed insights into development of cancer therapeutic through PD-L 1 inhibition.
Journal ArticleDOI

Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-α-induced inflammation in microglia cells.

TL;DR: Results indicate that SERT might treat depression by inhibiting the activation of microglia via the NF-κB signaling pathway and provides a basis for the research and development of antidepressants that act to reduce inflammation and the expression of inflammatory mediators.